Effect of electric field and ultrasound for transdermal drug delivery
US6041253A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Apr 1, 1996 |
| Grant date | Mar 21, 2000 |
| Priority date | — |
| Expiry date | Apr 1, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N1/0428
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Transdermal transport of molecules during sonophoresis (delivery or extraction) can be further enhanced by application of an electric field, for example, electroporation or iontophoresis. In a preferred embodiment the ultrasound is low frequency ultrasound which induces cavitation of the lipid layers of the stratum corneum (SC). This method provides higher drug transdermal fluxes, allows rapid control of transdermal fluxes, and allows drug delivery or analyte extraction at lower ultrasound intensities than when ultrasound is applied in the absence of an electric field.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.